The pancreatic islets in diabetes

Area of Science:

• Endocrinology
• Pathology
• Diabetes Research

Background:

• Diabetes mellitus is increasingly recognized as heterogeneous, yet pancreatic pathology is often categorized into juvenile-onset (insulin-dependent) and maturity-onset (non-insulin-dependent) types.
• Understanding the specific pancreatic changes in each diabetes type is crucial for elucidating disease mechanisms and developing targeted therapies.

Purpose of the Study:

• To delineate and compare the distinct pancreatic islet pathologies observed in insulin-dependent diabetes mellitus (IDDM) and non-insulin-dependent diabetes mellitus (NIDDM).
• To investigate the cellular and structural alterations within pancreatic islets in different forms of human diabetes.

Main Methods:

• Histopathological examination of pancreatic islets from patients with juvenile-onset and maturity-onset diabetes.
• Immunohistochemical analysis to identify endocrine cell populations (beta cells, alpha cells, somatostatin cells) and assess islet architecture.
• Morphometric analysis to quantify beta cell reduction and evaluate islet organization.

Main Results:

• Juvenile-onset diabetes (IDDM) is characterized by severe beta cell depletion and insulitis (inflammation) at clinical onset, with remaining islets showing glucagon and somatostatin cells and distorted organization.
• Maturity-onset diabetes (NIDDM) exhibits highly variable pancreatic pathology, including moderate beta cell reduction (not always accounting for disease severity) and potential beta cell dysfunction, with islet fibrosis/amyloidosis being common but not fully explanatory.
• Significant alterations in islet organization and endocrine cell distribution are observed in both types, suggesting complex pathogenetic mechanisms beyond simple cell loss.

Conclusions:

• The distinct pancreatic islet pathologies in IDDM and NIDDM support the heterogeneity of diabetes mellitus.
• IDDM pathology involves significant beta cell destruction and islet disorganization, potentially linked to autoimmune or viral factors.
• NIDDM pathology is more complex, involving variable beta cell dysfunction and altered islet architecture, necessitating further research into intercellular relationships and specific cellular defects.